BCR and COVID-19: Next Generation Sequencing (NGS) based deep clonotyping of either B cell receptors (BCR)12 or T cell receptors (TCR)13 have been applied in the context of COVID-19 severity and identified antibody features or shared TCRs in COVID-19 patients, respectively.